Veys EM - Search Results

1

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study.

Durez P, Van den Bosch F, Corluy L, Veys EM, De Clerck L, Peretz A, Malaise M, Devogelaer JP, Vastesaeger N, Geldhof A, Westhovens R. Durez P, et al. Among authors: veys em. Rheumatology (Oxford). 2005 Apr;44(4):465-8. doi: 10.1093/rheumatology/keh494. Epub 2005 Feb 3. Rheumatology (Oxford). 2005. PMID: 15695306

2

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.

Vander Cruyssen B, Van Looy S, Wyns B, Westhovens R, Durez P, Van den Bosch F, Veys EM, Mielants H, De Clerck L, Peretz A, Malaise M, Verbruggen L, Vastesaeger N, Geldhof A, Boullart L, De Keyser F. Vander Cruyssen B, et al. Among authors: veys em. Arthritis Res Ther. 2005;7(5):R1063-71. doi: 10.1186/ar1787. Epub 2005 Jul 8. Arthritis Res Ther. 2005. PMID: 16207323 Free PMC article.

3

Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).

VanderBorght A, De Keyser F, Geusens P, De Backer M, Malaise M, Baeten D, Van den Bosch F, Veys EM, Raus J, Stinissen P. VanderBorght A, et al. Among authors: veys em. J Rheumatol. 2002 Mar;29(3):416-26. J Rheumatol. 2002. PMID: 11908552 Clinical Trial.

4

Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration.

Elewaut D, De Keyser F, Van den Bosch F, Verbruggen G, Veys EM. Elewaut D, et al. Among authors: veys em. Clin Exp Rheumatol. 2000 Mar-Apr;18(2):201-7. Clin Exp Rheumatol. 2000. PMID: 10812492

5

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM. Van den Bosch F, et al. Among authors: veys em. Ann Rheum Dis. 2000 Jun;59(6):428-33. doi: 10.1136/ard.59.6.428. Ann Rheum Dis. 2000. PMID: 10834859 Free PMC article.

6

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.

Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P. Baeten D, et al. Among authors: veys em. Ann Rheum Dis. 2004 May;63(5):489-93. doi: 10.1136/ard.2003.012302. Ann Rheum Dis. 2004. PMID: 15082477 Free PMC article.

7

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.

De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F. De Rycke L, et al. Among authors: veys em. Ann Rheum Dis. 2005 Feb;64(2):299-302. doi: 10.1136/ard.2004.023523. Epub 2004 May 27. Ann Rheum Dis. 2005. PMID: 15166003 Free PMC article.

8

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.

Delabaye I, De Keyser F; REMITRACT study group. Delabaye I, et al. Arthritis Res Ther. 2010;12(3):R121. doi: 10.1186/ar3058. Epub 2010 Jun 22. Arthritis Res Ther. 2010. PMID: 20569501 Free PMC article.

9

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM. Van Den Bosch F, et al. Among authors: veys em. Arthritis Rheum. 2002 Mar;46(3):755-65. doi: 10.1002/art.511. Arthritis Rheum. 2002. PMID: 11920412 Free article. Clinical Trial.

10

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F. De Rycke L, et al. Among authors: veys em. Arthritis Rheum. 2003 Apr;48(4):1015-23. doi: 10.1002/art.10876. Arthritis Rheum. 2003. PMID: 12687543 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters